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to overread the degree of stenosis by noninvasive studies. 
At the time of the study, the technique for cervical evalua- 
tion was two-dimensional time-of-flight. We now perform 
three-dimensional time-of-flight and agree with Dr. Hart- 
nell that this is a more useful and accurate technique. 
Of note, the MRA scans were performed with a "gra- 
dient echo pulse sequence," not a "gradient echocardio- 
graphic pulse sequence," as stated in the article. 
It was not the intention of our article to totally exclude 
MRA from the clinical decisioumaldng process for carotid 
endarterectomy. If a patient comes to us with clear-cut 
carotid territory symptoms (or for that matter, asymptom- 
atic disease) with a technically good duplex ultrasound 
scan from our ACAS-certified vascular laboratory showing 
80% to 99% stenosis, then we would perform surgery on 
that patient on the basis of duplex ultrasound alone. If 
either the symptoms are not clearly carotid territory or the 
duplex ultrasound scan does not clearly show severe steno- 
sis, then we would proceed with MRA, now using three- 
dimensional time-of-flight in the neck, or in some in- 
stances proceed irectly to conventional rteriography. 
Harold J. Welch, MD 
William C. Mackey, MD 
Samuel M. Wolpert, MD 
Divisions of Vascular Surgery and Neuroradiology 
New England Medical Center 
750 Washington St. 
Boston, MA 02111 
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Regarding "Complications of  lilac artery stent 
deployment" 
To the Editors: 
I disagree with the premise of Ballard et al. (1996;24: 
545-55) that complications in percutaneous stent place- 
ment are underreported and that high technical success 
rates are the result of"adjunctive endovascular maneuvers" 
that should be considered "complications." The abstract 
claims that iliac artery stent placement was associated with 
a 19.4% incidence of procedure-related complications in
98 limbs. The manuscript describes two iliac artery rup- 
tures, two distal embolizations, and one stent infection, 
which are legitimate complications. However, this report 
also describes seven "dissections" associated with hemody- 
namically significant gradients that required additional 
stent placement, hree "dissections" that were not flow- 
limiting and did not require additional stent placement, 
and one stent "embolization" that was retrieved percuta- 
neously. 
Because "dissection" is necessary in percutaneous an- 
gioplasty and occurs with every successful procedure, 1 and 
because gradients were presumably present before stent 
placement, it is incorrect to consider many of these obser- 
vations "complications." Even the "embolized" Palmaz 
stent that was retrieved and an additional stent deployed 
can be disputed as a "complication." Stedman's Medical 
Dictionary defines "complication" as % morbid process or 
event occurring during a disease which is not an essential 
part of the disease.... "2Most of the events that the authors 
term "complications" were not associated with any mor- 
bidity, but relate to technical features of the procedure, 
analogous to placement of additional sutures in a leaky 
anastomosis. 
As a reference standard for defining complications, I 
would suggest reviewing experience with the surgical alter- 
native, which the authors conclude would be suitable for 
randomized comparison. Review of published surgical ex- 
perience with aortofemoral bypass grafting procedures for 
aortoiliac insufficiency that have been published since 1993 
reveals ix large series with a total of 1270 patients. 3-s The 
weighted surgical mortality rate was 4%, and the major 
complications rate was 21%. Complications included myo- 
cardial infarction, congestive heart failure, multisystem or- 
gan failure, stroke, spinal cord ischemia, intestinal infarc- 
tion, aortoenteric fistula, acute renal failure, respiratory, 
and so forth. These complications are similar to those 
described in practice guidelines published previously in the 
Journal of Vascular Surgery. 9The only remotely compara- 
ble complications in Ballard's article are three stent occlu- 
sions, two ruptures, one infection, and two distal emboli- 
zations, for a major complication rate of 8%. They reported 
no 30-day deaths. These results are consistent with those 
of previous reports of aortoiliac stenting.l° 13 The authors' 
call for randomization to stent placement or aortofemoral 
bypass grafting is not supported by their data or by previ- 
ous published experience. 
It would be unfortunate if patients were presented 
inflated "complication" rates such as these during discus- 
sions about treatment strategies. An important point that 
will hopefully not be missed when this report is cited is that 
technically successful results were achieved in 97% of pa- 
tients, surgical intervention was required in only 3%, and 
the 30-day mortality rate was 0%. Why would the authors 
consider this unworthy of mention in the discussion or in 
the conclusion of the abstract? It is interesting to note that 
despite concluding that iliac artery stent placement is "...an 
invasive procedure that has associated limb-threatening 
and life-threatening complications," midway through the 
trial they began performing them as outpatient procedures. 
How do the authors explain this paradox? 
Timothy P. Murphy, MD 
Director, Division of Vascular and Interventional Radiology 
Rhode Island Hospital 
593 Eddy St. 
Providence, RI 02903 
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Reply 
To the Editors: 
We appreciate the thoughtful and well-researched let- 
ter from Dr. Murphy. His reply is consistent with the 
outlook of most interventional radiologists as they report 
their experiences. 
A major point made by our report is that the format 
used by interventional r diologists i inconsistent with vas- 
cular surgical reporting standards. Dr. Murphy demon- 
strates the differing practices very well in his letter. For 
example, disputing the fact of an embolized stent as a 
complication is a clear deviation from vascular practice. 
Also, deployment of an additional $600 to $900 stent in 
the management ofhemodynamically significant iatrogenic 
dissections remote from or adjacent to the target lesion 
cannot be compared with placement of an additional su- 
ture in an anastomosis. In a recently presented update of 
our iliac stent experience, 1 we found the relative risk of a 
complication to be increased when multiple stents are used 
(relative risk, 2.65; p = 0.05) during the procedure. Fur- 
thermore, the relative risk of subsequent iliac artery throm- 
bosis was heavily influenced by the incidence of a proce- 
dure-related complication (relative risk, 15.33; p < 
0.0001). 
Dr. Murphy correctly makes the point that surgical 
intervention is more morbid than percutaneous angio- 
plasty. We have no disagreement with this fact and instead 
make a plea for uniform reporting of complications. As 
interventionalists and vascular surgeons work increasingly 
close together, it is crucial that they speak a common 
language~ Surgeons are trained to be meticulous in report- 
ing complications and in discussing them openly. Success- 
ful management of an untoward event as described by Dr. 
Murphy is a tribute to the skill of the interventional radiol- 
ogist but does not erase the fact of the complication. 
Lastly, although our experience demonstrates that outpa- 
tient iliac artery stent deployment can be done, that has not 
decreased our appreciation for the potential problems thac 
can occur with the procedure. 
As Dr. Murphy's letter provides trong evidence for 
the main point made in our article, we are grateful to him 
for taking the time to respond. 
Jeffrey L. Ballard, MD 
Division of Vascular Surgery 
Loma Linda Medical Center 
11234 Anderson St., Room 2586A 
Loma Linda, CA 92354 
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Regarding "Upper dorsal thoracoscopic 
sympathectomy for palmar hyperhidrosis: Improved 
intermediate-term results" 
To the Editors: 
Since 1990 we have performed more than 200 thora- 
coscopic sympathectomy procedures (in 100 patients) for 
palmar-axillary h perhidrosis or Raynaud's phenomenon. 
Contrary to the technique of Kopelman et al. (1996; 
24:194-9), we have always used double-lumen i tubation 
for ipsilateral lung collapse. Single-lumen intubation and 
CO2 insufflation entails the risk of tension pneumothorax 
and dramatic hemodynamic changes as a result of elevated 
intrathoracic pressures and is to be avoided, in our opinion. 
We have never seen postoperative atelectasis because 
we always ask the anesthesiologist to manually ventilate 
with positive end-expiratory pressure at the moment of 
instrument withdrawal. Only in one patient with bullous 
emphysema was postoperative thoracic drainage required, 
and all procedures were performed as planned. 
We operate with the patient in a semisupine position~, 
both sides consecutively, through two stab-wound inci- 
sions anterior on the chest in the second intercostal space. 
We are surprised by the high rate of complications (Hor- 
ner's syndrome, brachialgia) described by Dr. Kopelman et 
al., which we think are a result of.their surgical technique. 
We have always performed transpleural coagulation ofT2- 
T3-T4 ganglia, avoiding any dissection of or traction on 
the sympathetic chain. Performing this technique, we have 
